Breast Cancer Clinical Trial
Official title:
Evaluation of Persistent Postsurgical Pain After Breast Surgery With a Pectoral Nerves Block (Pecs) Type II: a Prospective Follow-up After a Prospective Double Blind Placebo-controlled Randomized Controlled Trail
Background and objectives The Pectoral Nerves Block (Pecs) Type II is a regional anesthesia
technique that provides post-surgical pain relief for patients undergoing breast surgery.
Post-procedural pain relief is known to diminish persistent pain. In this prospective
follow-up, the investigators evaluated whether the Pecs II block, compared to placebo, is
effective in reducing persistent post-procedural pain after breast cancer surgery in female
patients.
Patients and methods 140 breast cancer stage 1-3 patients undergoing mastectomy or
tumorectomy with sentinel node or axillary node dissection under general anesthesia were
randomized to receive a Pecs block (levobupivacaine 0.25%) or placebo (saline 0.9%). Patients
were invited between 9 and 31 months after surgery to complete a persistent postsurgical pain
survey.
Breast cancer is the most common cancer in women. For breast cancer patients, surgery is the
most effective therapeutic intervention. Up to two thirds of female patients undergoing
breast cancer surgery develop chronic post-procedural pain. This can be best understood by
the fact that chronic post-procedural pain is strongly associated with acute post-procedural
pain and that even minimal breast surgery can result in significant post-procedural pain.
Regional anesthesia techniques can improve acute and chronic post-procedural pain outcomes.
In the prospective double blind placebo-controlled randomized controlled trial, the
investigators found that the pectoral nerves (Pecs) block type II, as described by Blanco et
al., provides reliable and effective post-procedural analgesia for patients undergoing breast
surgery.
In this prospective follow-up, the investigators evaluate whether the Pecs II block is
effective in reducing chronic post-procedural pain in female adult patients undergoing breast
cancer surgery compared to placebo.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |